Fit4Surgery:评估卵巢癌肿瘤减灭术前预康复可行性的随机对照预试验
该预试验将30例≥60岁、计划接受新辅助化疗和手术的卵巢癌患者按2:1随机分为Fit4Surgery预康复组或教育对照组,主要结局为可行性(可评估率和依从性>80%)。结果显示90%患者完成基线和术前评估,Fitbit佩戴率94%、教练通话参与率97%、应用参与率80%,日均步数平均增加1804步(37%,p=0.01),患者报告的身体功能和衰弱相关指标在F4S组有改善趋势。
要点
- Fit4Surgery预康复方案在卵巢癌患者中可行,参与度和依从性高。
- 干预组日均步数平均增加1804步(37%,p=0.01),77.8%患者步数增加。
- 患者报告的身体功能(p=0.09)和衰弱相关指标如精力(p=0.01)、每周步行(p=0.02)在F4S组改善。
核心结论
- Fit4Surgery预康复方案可行,参与度和依从性高,患者日均步数增加,患者报告结局、衰弱和身体功能呈积极趋势。
研究设计与样本
- 随机对照预试验,30例年龄≥60岁、计划接受新辅助化疗和手术的卵巢癌患者按2:1随机分为Fit4Surgery组或教育对照组。
主要发现
- 74例患者被接触,32例同意,30例随机分组,平均年龄69.7岁(范围60-81)。
- 90%患者完成基线和术前评估,Fitbit佩戴率94%,教练通话参与率97%,F4S应用参与率80%。
- 患者49%的天数达到个人步数目标,77.8%患者日均步数增加,平均增加1804步/天(37%,p=0.01)。
- F4S组患者报告的身体功能(p=0.09)和衰弱相关指标包括精力(p=0.01)和每周步行(p=0.02)改善,手术结局无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the feasibility of enrolling women with ovarian cancer in a randomized controlled trial (RCT) of a home-based, patient-tailored physical activity prehabilitation program (Fit4Surgery, F4S) and assess adherence while estimating effects on patient-reported outcomes (PROs), frailty, and physical function. METHODS: Thirty patients aged ≥60 with ovarian cancer, scheduled for neoadjuvant chemotherapy and surgery, were randomized 2:1 to Fit4Surgery or educational control. The intervention group received a Fitbit, access to the F4S app, and weekly coaching calls. Controls received educational calls and access to the Cancer.Net app. The primary outcome was feasibility, defined as >80 % evaluability and adherence. Daily steps and PROs were compared using paired t-tests or Wilcoxon rank sum tests. RESULTS: Of 74 patients approached, 32 consented and 30 were randomized. Average age was 69.7 years (range 60-81). Ninety percent of patients completed both baseline and pre-surgical assessments. Patients wore their FitBit on 94 % of days, attended 97 % of coaching calls, and engaged with the F4S app on 80 % of days. Patients reached personal step goals on 49 % of days, while 77.8 % of patients increased their daily steps over the intervention, with an average increase of 1804 steps per day (37 % increase, p = 0.01). Patient-reported physical function (p = 0.09) and frailty-related metrics, including energy levels (p = 0.01) and weekly walks (p = 0.02) improved in the F4S group, while no differences were detected in surgical outcomes. CONCLUSIONS: Fit4Surgery was feasible with high engagement and adherence. Patients demonstrated increased daily step count and positive trends in PROs, frailty, and physical function.
引用
- Silberman JN, Benjamin A, Solk P, et al. Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer. Gynecol Oncol. 2025. PMID: 40616957. doi:10.1016/j.ygyno.2025.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。